E-drug: WHO/EDM Technical Briefing Seminar
-------------------------------------------------------------------------
Dear e-druggers,
The WHO Department of Essential Drugs and Medicines Policy, in
collaboration with the UNICEF Supply Division, is holding its annual
Technical Briefing Seminar for International Staff Active in
Pharmaceutical Support Programmes from 12-16 November in the
WHO Headquarters in Geneva. More details on target audience,
objectives and an outline of the programme are given below.
As usual, participation at the seminar is free of charge but
participants have to arrange for their own transport, board and
lodging. In case of oversubscription, preference will be given to
staff members of WHO, UN organisations, national governments,
non-governmental organisations and training institutions.
We look forward to seeing many of you with us in Geneva.
Robin Gray
Hans Hogerzeil
Department of Essential Drugs and Medicines Policy
World Health Organisation, Geneva
---------------------------------------------
WHO Technical briefing seminar for international staff active in
pharmaceutical support programmes
Organized by WHO Department of Essential Drugs and Medicines
Policy in collaboration with UNICEF Supply Division, Copenhagen
Venue: WHO Headquarters, Geneva, Salle G (8th floor)
Dates: 12-16 November 2001
Target audience
Technical advisers and field staff of WHO, UNICEF, other UN and
bilateral agencies and non-governmental organizations, active in
pharmaceutical and health sector support programmes in developing
countries.
Meeting objectives
By the end of the programme participants will:
1. have a general understanding of the most common problems in
the pharmaceutical sector in developing countries;
2. have a general understanding of how WHO and the UNICEF
Supply Division support developing countries in strengthening
the pharmaceutical sector;
3. appreciate the importance of national drug policies as the best
approach to make essential drugs of good quality available to all
who need them, and ensure the rational use of drugs;
4. be aware of ways to strengthen collaboration with WHO and
other organizations supporting the pharmaceutical sector in
developing countries.
Outline of the programme
Sessions will be devoted to developing national drug policies,
selection of essential drugs, access to essential drugs including
affordability and financing, the impact of globalisation and trade
agreements, drug regulation and quality assurance, drug
procurement and supply systems, promoting rational drug use, and
coordination between international agencies.
Structure of sessions
1. Presentation of main problems at country level, key approaches/
strategies, practical aspects of assistance to Member States, and
key documents
2. Small group discussion on the basis of 3-4 discussion points
3. Presentation by 2 groups (randomly selected) of outcome of their
discussion
Resource persons
Sessions will be lead by senior staff members of the WHO
Department of Essential Drugs and Medicines Policy. There will also
be some sessions by staff of UNICEF and other WHO clusters and
departments. One afternoon has been reserved for optional sessions
and two afternoons are available for individual appointments with
WHO staff.
Requests for further information and applications
Participation at the Technical Briefing Seminar is free of charge but
participants will have to arrange for their own travel, board and
lodging. Requests for more information and applications can be sent
to Mrs Ann Wilberforce, World Health Organization, EDM/PAR,
Geneva 1211, Switzerland, fax 41-22-7914167, e-mail
Wilberforcea@who.int
In case of oversubscription, preference will be given to staff
members of WHO, UN organisations, national governments,
non-governmental organisations and training institutions. Admission
to the seminar will be confirmed by 1 October 2001 at the latest.
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Information and archive http://www.healthnet.org/programs/edrug.html
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.